Autoimmune Test Portfolio

About CTK Biotech

CTK Biotech is a long-established, private player in the in-vitro diagnostics (IVD) market, specializing in lateral flow and ELISA-based tests for infectious diseases and autoimmune conditions. Operating in a competitive but stable market, the company likely generates revenue through the sale of its manufactured test kits and reagents to clinical labs globally. Its longevity since 2003 suggests a stable commercial footprint, though specific financial details and pipeline advancements are not publicly disclosed. The company's focus on established diagnostic modalities positions it in a mature segment with opportunities in geographic expansion and menu diversification.

Therapeutic Areas